The NCCI standard of care does not differentiate different courses of therapy based on HPV status. We all know it will change once sufficient studies are fully vetted and the medical community coalesces around the finding that the etiology of HPV p16+ is different and is treated differently.

Don
Male, 57 - Great health except C
Dec '12
DX: BOT SCC T2N2bMx, Stage 4a, HPV+, multiple nodes
1 tooth out
Jan '13
2nd tooth out
Tumor Board -induction TPF (3 cycles), seq CRT
4-6/2013
CRT 70gr 2x35, weekly carbo150
ended 5/29,6/4
All the details, join at http://beatdown.cognacom.com